---
figid: PMC4113681__10555_2014_9497_Fig1_HTML
figtitle: Representative regulators of the Sprouty cellular content at transcriptional
  and post-translational level irrespective of the Sprouty isoform and cell type
organisms:
- NA
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC4113681
filename: 10555_2014_9497_Fig1_HTML.jpg
figlink: /pmc/articles/PMC4113681/figure/Fig1/
number: F1
caption: Representative regulators of the Sprouty cellular content at transcriptional
  and post-translational level irrespective of the Sprouty isoform and cell type.
  MAPK/ERK is the main pathway to upregulate Sprouty. Transcription factors WT1 and
  PPARγ and Wnt/β-catenin signaling pathway have also been shown to upregulate Sprouty.
  miR-21 is a cancer-associated microRNA that targets and negatively regulates the
  Sprouty genes. TGFβ1 not only downregulates the expression of Sprouty, but also
  induces the protein degradation via a lysosome-dependent pathway. E3 ubiquitin ligases
  c-Cbl, Siah2, NEDD4, and pVHL induce degradation of Sprouty to regulate its cellular
  content. PP2A competes with c-Cbl for binding to Sprouty, thereby inhibiting c-Cbl-mediated
  degradation of Sprouty. Mnk1 is a positive regulator of the Sprouty stability through
  serine phosphorylation. c-Cbl canonical Casitas B-lineage lymphoma; FZD receptor
  Frizzled receptor; miR-21 microRNA 21; Mnk1 MAPK-interacting kinase 1; NEDD4 neural
  precursor cell expressed, developmentally down-regulated 4; PP2A protein phosphatase
  2A; PPARγ peroxisome proliferator-activated receptor gamma; RTK receptor tyrosine
  kinase; Siah2 Seven in Absentia homolog 2; WT1 Wilms tumor suppressor 1; CS rearrangement
  cytoskeletal rearrangement. In this figure, C- and N-terminus of the Sprouty molecule
  symbol are shown in white and blue, respectively
papertitle: The developing story of Sprouty and cancer.
reftext: Samar Masoumi-Moghaddam, et al. Cancer Metastasis Rev. 2014;33(2-3):695-720.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9741658
figid_alias: PMC4113681__F1
figtype: Figure
redirect_from: /figures/PMC4113681__F1
ndex: 054d8776-dec2-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4113681__10555_2014_9497_Fig1_HTML.html
  '@type': Dataset
  description: Representative regulators of the Sprouty cellular content at transcriptional
    and post-translational level irrespective of the Sprouty isoform and cell type.
    MAPK/ERK is the main pathway to upregulate Sprouty. Transcription factors WT1
    and PPARγ and Wnt/β-catenin signaling pathway have also been shown to upregulate
    Sprouty. miR-21 is a cancer-associated microRNA that targets and negatively regulates
    the Sprouty genes. TGFβ1 not only downregulates the expression of Sprouty, but
    also induces the protein degradation via a lysosome-dependent pathway. E3 ubiquitin
    ligases c-Cbl, Siah2, NEDD4, and pVHL induce degradation of Sprouty to regulate
    its cellular content. PP2A competes with c-Cbl for binding to Sprouty, thereby
    inhibiting c-Cbl-mediated degradation of Sprouty. Mnk1 is a positive regulator
    of the Sprouty stability through serine phosphorylation. c-Cbl canonical Casitas
    B-lineage lymphoma; FZD receptor Frizzled receptor; miR-21 microRNA 21; Mnk1 MAPK-interacting
    kinase 1; NEDD4 neural precursor cell expressed, developmentally down-regulated
    4; PP2A protein phosphatase 2A; PPARγ peroxisome proliferator-activated receptor
    gamma; RTK receptor tyrosine kinase; Siah2 Seven in Absentia homolog 2; WT1 Wilms
    tumor suppressor 1; CS rearrangement cytoskeletal rearrangement. In this figure,
    C- and N-terminus of the Sprouty molecule symbol are shown in white and blue,
    respectively
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - XYLT2
  - SOS1
  - SOS2
  - KRAS
  - HRAS
  - NRAS
  - ADAR
  - DVL1P1
  - CBL
  - GAB1
  - PIGU
  - SIAH2
  - PIK3R1
  - PIK3R2
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - CRK
  - NEDD4
  - CTNNB1
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - VHL
  - RHOA
  - RAC1
  - RNASE1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - CDC42
  - PTPA
  - AKT1
  - AKT2
  - AKT3
  - CS
  - NOS3
  - ENO4
  - MYC
  - RPS6KA1
  - RPS6KA2
  - RPS6KA3
  - RPS6KA4
  - RPS6KA5
  - RPS6KA6
  - RPS6KB1
  - RPS6KB2
  - TGFB1
  - SPRY1
  - SPRY2
  - SPRY3
  - SPRY4
  - HNF4A
  - MIR21
  - SH3KBP1
  - PTPN11
  - GRB2
  - MKNK1
  - Wnt5
  - Wnt4
  - wg
  - Wnt2
  - Tie
  - Ras85D
  - InR
  - fz
  - Sos
  - ras
  - Ras64B
  - dsh
  - Cbl
  - dos
  - Myb
  - Pi3K21B
  - Taf5
  - Crk
  - .na.character
  - arm
  - Raf
  - Rho1
  - Rac1
  - Rac2
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Cdc42
  - wrd
  - wdb
  - mts
  - tws
  - Pp2A-29B
  - Akt
  - cs
  - Myc
  - S6kII
  - sty
  - pan
  - csw
  - drk
  - P Serine
  - Serine
  - Cancer
  - Noonan syndrome
---
